Scientists at the University of Florida have created a breakthrough mRNA cancer vaccine that erased deadly brain tumors in early human trials without chemo or radiation.

Scientists at the University of Florida have developed an experimental mRNA cancer vaccine that showed promising results in early human trials by triggering a strong immune response against deadly brain tumors without the use of chemotherapy or radiation.

New mRNA cancer vaccine triggers fierce immune response to fight malignant brain tumor - UF Health
Source: ufhealth.org

New mRNA cancer vaccine triggers fierce immune response to fight malignant brain tumor - UF Health
Source: ufhealth.org

At a glance

Key Evidence

Verified August 19, 2025

The first-ever human clinical trial at UF involved four adult patients with glioblastoma, where the mRNA vaccine triggered a fierce immune response without chemo or radiation.news.ufl.edu ufhealth.org
Follow-up research is advancing toward universal cancer vaccines by boosting immunotherapy effects in mouse models.mbi.ufl.edu news.ufl.edu
The vaccine’s ability to reprogram the immune system quickly was highlighted as a significant breakthrough by UF Health Cancer Center researchers.cancer.ufl.edu

The reporting

What the Evidence Shows

The University of Florida researchers developed an mRNA vaccine targeting glioblastoma, a highly aggressive and lethal brain tumor.

Early human clinical trials involving four adult patients demonstrated that the vaccine rapidly reprogrammed the immune system to attack the tumor cells.

These trials did not involve chemotherapy or radiation, highlighting the vaccine's potential as a standalone immunotherapy approach.

While the initial results are promising, the trials were very small and preliminary, so further research and larger clinical trials are necessary to confirm efficacy and safety.

Subsequent studies at UF have also explored combining this mRNA vaccine with immunotherapy in animal models, moving toward a universal cancer vaccine concept.

Overall, the claim accurately reflects the breakthrough nature and early success of the UF mRNA cancer vaccine in brain tumor treatment but should be understood as preliminary and part of ongoing research rather than a definitive cure.

Primary trail